Fast start for coronavirus drug boosts Gilead earnings, sends stock higher in late tradingMarket Watch • 10/28/20
Gilead is set to sell billions of dollars of a coronavirus drug that's far from 'amazing' after the US approved remdesivir to treat COVID-19Business Insider • 10/24/20
3 important things to know about remdevisir, the first FDA-approved coronavirus treatmentMarket Watch • 10/23/20
Doctors question FDA approval of Gilead's COVID-19 treatment and say it has limited benefitsMarket Watch • 10/23/20